Inventor · disambiguated record
Paul N. Mudd, Jr.
Also filed as: MUDD JR PAUL N · MUDD PAUL · MUDD PAUL NORMAN
11 granted patents·10 pending applications·53 citations·filing 2001–2025
90Inventor score
Files withSUMITOMO PHARMA SWITZERLAND GMBH7UROVANT SCIENCES GMBH7MYOVANT SCIENCES GMBH4SB PHARMCO PURERTO RICO INC TH1SUMITOMO PHARMA CO LTD1
Top patents by PatentIndex Score
21 records- 0197US11583526B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2020·Granted Feb 21, 2023·9 cites·18 claims
- 0297US10449191B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2019·Granted Oct 22, 2019·13 cites·23 claims
- 0396US10786501B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2019·Granted Sep 29, 2020·12 cites·10 claims
- 0495US12144809B1Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2024·Granted Nov 19, 2024·3 cites·29 claims
- 0595US12097198B2Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2022·Granted Sep 24, 2024·4 cites·20 claims
- 0693US12336990B2Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2024·Granted Jun 24, 2025·1 cites·30 claims
- 0792US11957684B2Treatment of heavy menstrual bleeding associated with uterine fibroidsSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2022·Granted Apr 16, 2024·2 cites·22 claims
- 0891US11793812B2Methods of treating endometriosisSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2021·Granted Oct 24, 2023·2 cites·4 claims
- 0991US11033551B2Methods of treating uterine fibroidsMYOVANT SCIENCES GMBH·Filed 2019·Granted Jun 15, 2021·6 cites·26 claims
- 1089US2025082632A1Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1187US2025332166A1Treatment of prostate cancerSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1280US2024165118A1Treatment of Heavy Menstrual Bleeding Associated with Uterine FibroidsSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 1370US12102638B2Use of vibegron to treat overactive bladderUROVANT SCIENCES GMBH·Filed 2018·Granted Oct 1, 2024·1 cites·54 claims
- 1457US2023218624A1Dosing of vibegron for treatment of overactive bladderUROVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 1554US12357636B2Vibegron for the treatment of overactive bladder symptomsUROVANT SCIENCES GMBH·Filed 2019·Granted Jul 15, 2025·0 cites·29 claims
- 1654US2024050457A1Methods of monitoring digoxin with concomitant use of vibegron to treat overactive bladderUROVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 1744US2023027066A1Use of vibegron to treat overactive bladderUROVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 1841US2008206336A1Novel Composition Comprising Rosiglitazone and Another Antidiabetic AgentSB PHARMCO PURERTO RICO INC TH·Filed 2004·Application pending·0 cites
- 1940US2021196720A1Use of vibegron to treat pain associated with irritable bowel syndromeUROVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 2037US2021077496A1Dosing of vibegron for treatment of overactive bladderUROVANT SCIENCES GMBH·Filed 2018·Application pending·0 cites
- 2135US2002166920A1Method and apparatus for fabrication of a self-supporting banded coilFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul N. Mudd, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →